Ashwani Bahl

Dr Ashwani Bahl is a Senior Director in Corporate Business Development at Eli Lilly and Company. Dr Bahl is based at the Lilly UK site in Erl Wood and has responsibility for leading R&D input into strategic collaborations with venture partners, academia and public institutes. Dr Bahl has over 20 years of experience within the pharmaceutical industry his previous roles were with AstraZeneca (1994-2011 as Vice President of R&D New Opportunities) and Glaxo (1990-1994). Dr Bahl did his first degree in Pharmacy at Kings College London and then a PhD in Immunology at University College London (UCL).